The role of DNA damage inducible Polo-like kinase 2 as a tumor suppressor and target for therapy.

被引：0
|
作者：
Matthew, Elizabeth
Hart, Lori
Astrinidis, Aristotelis
Navaraj, Arunasalam
Dolloff, Nathan
El-Deiry, Wafik
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Drexel Univ, Philadelphia, PA 19104 USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
618
引用
收藏
页数：1
相关论文
共 50 条
  • [21] POLO-LIKE KINASE 1 AS A POTENTIAL TARGET IN PEDIATRIC MEDULLOBLASTOMA
    Pezuk, Julia Alejandra
    Brassesco, Maria Sol
    de Oliveira, Jaqueline Carvalho
    Morales, Andressa Gois
    Queiroz, Rosane
    Scrideli, Carlos Alberto
    Valera, Elvis Tercy
    Tone, Luiz Gonzaga
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1092 - 1092
  • [22] Role for polo-like kinase 4 in mediation of cytokinesis
    Press, Michael F.
    Xie, Bin
    Davenport, Simon
    Zhou, Yu
    Guzman, Roberta
    Nolan, Garry P.
    O'Brien, Neil
    Palazzolo, Michael
    Mak, Tak W.
    Brugge, Joan S.
    Slamon, Dennis J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (23) : 11309 - 11318
  • [23] Polo-Like Kinase 1 as a Potential Therapeutic Target for Osteosarcoma
    Cheng, Li
    Wang, Chongchong
    Jing, Juehua
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (10) : 1347 - 1350
  • [24] Polo-like kinase 1 - Target and regulator of transcriptional control
    Martin, Bernd T.
    Strebhardt, Klaus
    CELL CYCLE, 2006, 5 (24) : 2881 - 2885
  • [25] Identification of polo-like kinase as a therapeutic target in murine lupus
    Li, Yaxi
    Wang, Hongting
    Zhang, Zijing
    Tang, Chenling
    Zhou, Xinjin
    Mohan, Chandra
    Wu, Tianfu
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2022, 11 (01)
  • [26] A novel role for polo-like kinase 2 in modulating atrial fibrosis
    Kunzel, S.
    Meyer-Roxlau, S.
    Radon, L.
    Schaeffer, C.
    Joos, J.
    Yin, X.
    Haudebourg, E.
    Mayr, M.
    El-Armouche, A.
    Weber, S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 : S31 - S31
  • [27] Polo-like kinase 3 functions as a tumor suppressor and is a negative regulator of hypoxia-inducible factor-1α under hypoxic conditions
    Yang, Yali
    Bai, Jingxiang
    Shen, Rulong
    Brown, Sharron A. N.
    Komissarova, Elena
    Huang, Ying
    Jiang, Ning
    Alberts, Gregory F.
    Costa, Max
    Lu, Luo
    Winldes, Jeffrey A.
    Dai, Wei
    CANCER RESEARCH, 2008, 68 (11) : 4077 - 4085
  • [28] Development of a Polo-like Kinase-1 Polo-Box Domain Inhibitor as a Tumor Growth Suppressor in Mice Models
    Gunasekaran, Pethaiah
    Yim, Min Su
    Ahn, Mija
    Soung, Nak-Kyun
    Park, Jung-Eun
    Kim, Jaehi
    Bang, Geul
    Shin, Sang Chul
    Choi, Joonhyeok
    Kim, Minkyoung
    Kim, Hak Nam
    Lee, Young-Ho
    Chung, Young-Ho
    Lee, Kyeong
    Kim, Eunice EunKyeong
    Jeon, Young-Ho
    Kim, Min Ju
    Lee, Kyeong-Ryoon
    Kim, Bo-Yeon
    Lee, Kyung S.
    Ryu, Eun Kyoung
    Bang, Jeong Kyu
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (23) : 14905 - 14920
  • [29] Polo-box domains confer target specificity to the Polo-like kinase family
    van de Weerdt, Barbara C. M.
    Littler, Dene R.
    Klompmaker, Rob
    Huseinovic, Angelina
    Fish, Alex
    Perrakis, Anastassis
    Medema, Rene H.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2008, 1783 (06): : 1015 - 1022
  • [30] Roles of Polo-like kinase 3 in suppressing tumor angiogenesis
    Xu, Dazhong
    Wang, Qi
    Jiang, Yongping
    Zhang, Yanxi
    Vega-SaenzdeMiera, Eleazar
    Osman, Iman
    Dai, Wei
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2012, 1
12345